Home » Topics » BioWorld Science

BioWorld Science
RSS

Biogen describes new OGA inhibitors

April 8, 2020

New USP9X inhibitors identified by FORMA Therapeutics

April 8, 2020

Investigator-initiated IND application filed to study CORVax12 to prevent COVID-19

April 8, 2020

Forge Therapeutics presents new bacterial LpxC inhibitors

April 8, 2020

Beijing Yuezhikangtai Biomedicines discloses VEGFR inhibitors

April 8, 2020

Roche patents Toll-like receptor antagonists

April 8, 2020

Preclinical data support development of WZ-66 for NASH

April 8, 2020

IXT-v100 vaccine decreases meth-taking and -seeking behaviors in vivo

April 8, 2020

Researchers in Montreal and NYU partner on new COVID-19 clinical study

April 8, 2020

Catalyst announces pivotal phase III design for MarzAA

April 8, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...